In vitro inhibitory effect of rupatadine on histamine and TNF-α release from dispersed canine skin mast cells and the human mast cell line HMC-1

Inflammation Research

Volumn 49, Issue 7, 2000, Pages 355-

  Queralt, M ^a   Brazis, P ^a   Merlos, M ^b   De Mora, F ^a   Puigdemont, A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Grupo Uriach   (Spain)

Author keywords

Histamine; Mast cells; Rupatadine; TNF

Indexed keywords

ANTIBODY; ANTIHISTAMINIC AGENT; CALCIMYCIN; CONCANAVALIN A; CYPROHEPTADINE; DRUG DERIVATIVE; FOROPAFANT; IMMUNOGLOBULIN E; LORATADINE; RUPATADINE; THIAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DOG; DRUG EFFECT; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY; MAST CELL; PHYSIOLOGY; SECRETION; SKIN;

ANIMALS; ANTIBODIES; CALCIMYCIN; CELL LINE; CONCANAVALIN A; CYPROHEPTADINE; DOGS; HISTAMINE ANTAGONISTS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; LORATADINE; MAST CELLS; SKIN; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034221301     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000216     Document Type: Article

References (27)

1. 1-receptor antagonists. Allergy 1997; 52: 7-13.
2. 1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995; 4: 272-6.
3. Leal-Berumen I, Snider D, Barajas-López C, Marshall J. Cholera toxin increases IL-6 synthesis and decreases TNF-α production by rat peritoneal mast cells. J Immunol 1996; 156: 316-21.
4. Hide I, Toriu N, Nuibe T, Inoue A, Hide M, Yamamoto S, et al. Suppression of TNF-α secretion by azelastine in a rat mast (RBL-2H3) cell line. J Immunol 1997; 159: 2932-40.
5. Bissonnete E, Enciso J, Dean Befus A. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-α production by mast cells. J Immunol 1996; 156: 218-23.
6. Kruger-Krasagakes S, Möller A, Kolde G, Lippert U, Weber M, Henz B. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996; 106: 75-9.
7. Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 1997; 280: 114-21.
8. Queralt M, Merlos M, Giral M, Puigdemont A. Dual effect of a new compound,rupatadine, on edema induced by platelet-activating factor and histamine in dogs: comparison with antihistamines and PAF-antagonists. Drug Dev Res 1996; 39: 12-8.
9. Queralt M, Brazis C, Merlos M, Puigdemont A. Inhibitory effects of rupatadine on mast cell histamine release and skin wheal development induced by Ascaris suum in hypersensitive dogs. Drug Dev Res 1998; 44: 49-55.
10. Merlos M, Balsa D, Giral M, Ferrando R, García-Rafanell J, Forn J. Inhibition of rat peritoneal mast cell exocytosis by rupatadine fumarate: a study with different secretagogues. Methods Find Exp Clin Pharmacol 1997; 19: 148.
11. Merlos M, Giral M, Balsa D, Ferrando R, García-Rafanell J, Forn J. Rupatadine inhibits the eosinophil recruitment in BAL fluid of ovalbumin-sensitized guinea pigs. J Allergy Clin Immunol 1998; 101: S 218.
12. De Week A, Mayer P, Stumper B, Schiessi B, Pickart L. Dog allergy, a model for allergy genetics. Int Arch Allergy Immunol 1997; 113: 55-7.
13. Brazis P, Queralt M, De Mora F, Ferrer L, Puigdemont A. Comparative study of histamine release from skin mast cells dispersed from atopic, ascaris-sensitive and healthy dogs. Vet Immunol Immunopathol 1998; 66: 43-51.
14. 1-antihistamines on histamine release from dispersed canine cutaneous mast cells. Am J Vet Res 1997; 58/3: 293-297.
15. De Mora F, García G, Ferrer L, Arboix M. Canine cutaneous mast cells dispersion and histamine secretory characterization. Vet Immunol Immunopathol 1993; 39: 421-29.
16. Kimura I, Moritani Y., Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 1973; 3: 195-202.
17. Shore PA, Burkhalter A, Cohn VH. A method for the fluorimetric assay of histamine in tissues. J Pharmacol Exp Ther 1959; 127: 179-86.
18. 1-antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 1994; 105: 12-7.
19. García G, Brazís P, Majó N, Ferrer L, De Mora F, Puigdemont A. Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cell, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. Vet Immunol Immunopathol 1998; 62: 323-37.
20. Carnuccio R, Di Rosa M, Ialenti A, Iuvone T, Sautebin L. Selective inhibition by vasocortin of histamine release induced by dextran and concanavalin A from rat peritoneal cells. Br J Pharmac 1989; 98: 32-4.
21. Amon U, Nitsche M, Dieckmann D, Gibbs B, Wehrhahn C, Wolff H. Activation and inhibition of mediator release from skin mast cells: a review of in vitro experiments. Clin Exp Allergy 1994; 24: 1098-104.
22. Paulussen J, Fischer M, Roelofsen E, Horbach D, de Mol N, Janssen L. Oxatomide and derivatives as inhibitors of mediator release from mast cells model. Arzneimittelforsch 1996; 46: 496-501.
23. Genovese AP, De Crescenzo G, De Paulis A, Spadaro, G, Marone G. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FcRI cells. Clin Exp Allergy 1997; 27: 559-67.
24. Benlounes N, Dupont C, Candalh C, Blaton M, Bloom M and Heyman M. Effect of terfenadine on TNF-α release from peripheral blood mononuclear cells during cow's milk allergy. Clin Exp Allergy 1997; 27: 942-48.
25. Huang Y, Shäfer-Elinder L, Hu R, Claesson H, Frostegard J. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 1999; 116: 326-31.
26. 2-type cytokine production from human peripheral T cells by terfenadine in vitro. Clin Exp Allergy 1999; 29: 1281-86.
27. Baumgartner R, Deramo V, Beaven M. Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. J Immunol 1996; 157: 4087-93.